Nova Biomedical Corp.: FDA filings under this applicant name

FDA lists 129 510(k) clearances under 2 spellings of the applicant name “Nova Biomedical Corp.” (first 1977, latest 2026), across 32 product codes in 2 review panels. Median 510(k) review time under this name: 78 days. Since 2017 the median was 180 days, against 231 days for all cleared 510(k)s in the same product codes. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.

510(k) clearances per year

YearClearancesMedian review days
20123132
20132200
20143287
2015488
20163132
20174156
20187180
2019258
2020458
20210—
20221683
20231456
20243881
20250—
20262226

Review time against the same product codes

Since 2017, 510(k)s cleared under the name Nova Biomedical Corp. took a median 180 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 231 days.

Top product codes

Product codeDeviceSubmissions510(k) clearances
CHLElectrode Measurement, Blood-Gases (Pco2, Po2) And Blood Ph2828
JGSElectrode, Ion Specific, Sodium2121
PZIPrescription Use Blood Glucose Meter For Near-Patient Testing1010
JJYMulti-Analyte Controls, All Kinds (Assayed)88
CGAGlucose Oxidase, Glucose77
JFPElectrode, Ion Specific, Calcium66
NBWSystem, Test, Blood Glucose, Over The Counter66
CEMElectrode, Ion Specific, Potassium44
CGLElectrode, Ion Based, Enzymatic, Creatinine33
GKFInstrument, Hematocrit, Automated33

Plus 22 more product codes.

Review panels

Most recent Nova Biomedical Corp. 510(k) clearances

510(k)DeviceProduct codeDecision dateReview days
K251281Nova Max Creat eGFR Monitoring SystemSHB2026-01-21272
K252206Nova Allegro UACR Assay, Nova Allegro AnalyzerCGX2026-01-09179
K221326Nova Allegro HbA1c Assay, Nova Allegro AnalyzerLCP2024-11-22931
K221813Nova Allegro UACR Assay, Nova Allegro AnalyzerCGX2024-11-19881
K232075StatStrip Glucose Hospital Meter SystemPZI2024-02-23226
K221900Stat Profile Prime Plus Analyzer SystemCHL2023-09-29456
K203549Nova Primary Glucose Analyzer SystemCGA2022-10-18683
K200403Stat Profile Prime Plus Analyzer SystemJGS2020-04-1455
K200204Stat Profile Prime Plus Analyzer SystemGGZ2020-04-0669
K200349Stat Profile Prime Plus Analyzer SystemCGA2020-03-1330

119 earlier clearances. See the full list in Caduvo.

Recalls

41 product recalls in 15 recall events; 10 initiated in the last five years. Most recent: 2026-07-29.

Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.

Device clinical trials

An industry sponsor named Nova Biomedical Corp. is the lead sponsor of 1 device studies on ClinicalTrials.gov (0 active or recruiting). Most recent:

FDA spellings included

FDA records this applicant under 2 spellings (case, punctuation and legal-suffix variants of one name); this page adds them up. Filings per spelling:

Other FDA applicant names starting with the same word

FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.

Frequently asked questions

How many FDA 510(k) clearances are listed under Nova Biomedical Corp.?

FDA lists 129 510(k) clearances under 2 spellings of the applicant name “Nova Biomedical Corp.” (first 1977, latest 2026), across 32 product codes in 2 review panels. Filings under other applicant names, such as subsidiaries, are not included.

How long has FDA taken to clear 510(k)s filed by Nova Biomedical Corp.?

The median time from FDA receipt to decision across 510(k)s cleared under the name Nova Biomedical Corp. is 78 days. Since 2017: 180 days, versus 231 days for all cleared 510(k)s in the same product codes.

Which FDA product codes appear under Nova Biomedical Corp.?

The most frequent FDA product codes under this applicant name are CHL (Electrode Measurement, Blood-Gases (Pco2, Po2) And Blood Ph, 28); JGS (Electrode, Ion Specific, Sodium, 21); PZI (Prescription Use Blood Glucose Meter For Near-Patient Testing, 10).

Next steps

Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant names shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.

All FDA device companies · FDA product code lookup